methyl N-cyclohexyloxamate | 86072-19-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: methyl N-cyclohexyloxamate
• 英文别名: methyl 2-(cyclohexylamino)-2-oxoacetate；cyclohexyl-oxalamic acid methyl ester；Cyclohexyl-oxalamidsaeure-methylester；Cyclohexyloxamidsaeure-methylester
• CAS: 86072-19-7
• 化学式: C₉H₁₅NO₃
• 分子量: 185.223
• InChiKey: GNRAIKPENKRQJC-UHFFFAOYSA-N

物化性质

• 熔点：
  73 °C
• 密度：
  1.10±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  13
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.78
• 拓扑面积：
  55.4
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl N-cyclohexyloxamate 在 copper diacetate 、 silver nitrate 氢氧化钾 、 ammonium peroxydisulfate 作用下， 以 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 3.0h， 生成 环己基异氰酸酯
  参考文献：
  名称：

  Reactivity of Carbamoyl Radicals. A New, General, Convenient Free-Radical Synthesis of Isocyanates from Monoamides of Oxalic Acid

  摘要：

  A new, general, simple synthesis of isocyanates was developed by oxidation of monoamides of oxalic acid with peroxydisulfate catalyzed by Ag and Cu salts. The reaction was carried out in a two-phase system (water and an organic solvent), and it is suitable also for practical applications, due to the simple experimental conditions and the inexpensive as well as nontoxic reagents. The first example of homolytic intramolecular aromatic carbamoylation is also reported.

  DOI：

  10.1021/jo00122a020
• 作为产物：
  描述：

  甲基戊酰氯 、 环己胺 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 反应 24.0h， 以65%的产率得到methyl N-cyclohexyloxamate
  参考文献：
  名称：

  α-酮酰胺的不对称转移氢化；苹果酸二酰胺和α-羟基酰胺的高度对映选择性形成

  摘要：

  使用系留的 Ru/TsDPEN 催化剂在高 ee 下实现了 α-酮基-1,4-二酰胺的不对称转移氢化（ATH）。对衍生物的研究确定了导致产品中最高对映选择性的结构元素。α-酮酰胺还原产物已转化为一系列具有合成价值的衍生物。

  DOI：

  10.1021/acs.orglett.1c02830

文献信息

• Photoinduced Alcoholysis of Trihaloacetyl Group
  作者：Yasuji Izawa、Katsuhiro Ishiguro、Hideo Tomioka

  DOI：10.1246/bcsj.56.951

  日期：1983.3

  Photolysis of trichloroacetamide in nondegassed methanol gave methyl oxanilate (13–44%), along with carbamate (3–20%) and amine (4–12%). Similar irradiation of other trichloroacetyl derivatives of aliphatic ketone, aldehyde, and acetate afforded only radical product. The results are interpreted in terms of the mechanism involving electron transfer of the radical pair.

  三氯乙酰胺在未脱气的甲醇中的光解得到草胺酸甲酯 (13-44%)、氨基甲酸酯 (3-20%) 和胺 (4-12%)。脂肪族酮、醛和乙酸酯的其他三氯乙酰衍生物的类似辐照仅提供自由基产物。根据涉及自由基对电子转移的机制来解释结果。
• First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease
  作者：Steven D. Linton、Teresa Aja、Robert A. Armstrong、Xu Bai、Long-Shiuh Chen、Ning Chen、Brett Ching、Patricia Contreras、Jose-Luis Diaz、Craig D. Fisher、Lawrence C. Fritz、Patricia Gladstone、Todd Groessl、Xin Gu、Julia Herrmann、Brad P. Hirakawa、Niel C. Hoglen、Kathy G. Jahangiri、Vincent J. Kalish、Donald S. Karanewsky、Lalitha Kodandapani、Joseph Krebs、Jeff McQuiston、Steven P. Meduna、Kip Nalley、Edward D. Robinson、Robert O. Sayers、Kristen Sebring、Alfred P. Spada、Robert J. Ternansky、Kevin J. Tomaselli、Brett R. Ullman、Karen L. Valentino、Suzanne Weeks、David Winn、Joe C. Wu、Pauline Yeo、Cheng-zhi Zhang

  DOI：10.1021/jm050307e

  日期：2005.11.1

  A series of oxamyl dipeptides were optimized for pan caspase inhibition, anti-apoptotic cellular activity and in vivo efficacy. This structure-activity relationship study focused on the P4 oxamides and warhead moieties. Primarily on the basis of in vitro data, inhibitors were selected for study in a murine model of alpha-Fas-induced liver injury. IDN-6556 (1) was further profiled in additional in vivo

  针对泛半胱天冬酶抑制，抗凋亡细胞活性和体内功效优化了一系列草酰二肽。这项结构-活性关系研究的重点是P4乙酰胺和弹头部分。主要根据体外数据，在α-Fas诱导的肝损伤小鼠模型中选择抑制剂进行研究。IDN-6556（1）在其他体内模型和药代动力学研究中得到了进一步的描述。现在，这种一流的胱天蛋白酶抑制剂已成为两项II期临床试验的主题，评估了其在肝病中使用的安全性和有效性。
• [EN] OXALAMIDE HETEROBYCYCLIC COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH STING ACTIVITY<br/>[FR] COMPOSÉS OXALAMIDE HÉTÉROBYCYCLIQUES ET COMPOSITIONS POUR LE TRAITEMENT D'AFFECTIONS ASSOCIÉES À UNE ACTIVITÉ DE STING
  申请人：IFM DUE INC

  公开号：WO2021067805A1

  公开（公告）日：2021-04-08

  This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt, and/or hydrate, and/or cocrystal, and/or drug combination of the compound) that inhibit (e.g., antagonize) Stimulator of Interferon Genes (STING). Said chemical entities are useful, e.g., for treating a condition, disease or disorder in which increased (e.g., excessive) STING activation (e.g., STING signaling) contributes to the pathology and/or symptoms and/or progression of the condition, disease or disorder (e.g., cancer) in a subject (e.g., a human). This disclosure also features compositions containing the same as well as methods of using and making the same.

  本公开涉及化学实体（例如，化合物或药用盐，和/或水合物，和/或共晶，和/或化合物的药物组合），其抑制（例如，拮抗）干扰素基因激活器（STING）。所述化学实体可用于治疗条件、疾病或障碍，其中增加（例如，过度）STING激活（例如，STING信号传导）对主体（例如，人类）的病理和/或症状和/或疾病或障碍的进展有贡献。本公开还涉及含有相同化学实体的组合物，以及使用和制备这些组合物的方法。
• 10.1002/chem.202401419
  作者：Vincent, Émilie、Brioche, Julien

  DOI：10.1002/chem.202401419

  日期：——

  A combination of silver oxide (Ag2O) catalyst, potassium persulfate (K2S2O8) and SelectfluorTM was identified to perform radical carbofluorination reactions of olefin and α-fluoroolefin substrates with carbamoyl radicals generated in situ from sodium oxamate salts. Both transformations proceed under mild conditions and provide respectively a straightforward access to β-fluoroamides and β,β-difluoroamides

  氧化银 (Ag 2 O) 催化剂、过硫酸钾 (K 2 S 2 O 8 ) 和 Selectflor TM 的组合被确定可利用草酸钠盐原位产生的氨基甲酰基自由基进行烯烃和α-氟烯烃底物的自由基碳氟化反应。两种转化均在温和条件下进行，并分别提供了直接获得β-氟酰胺和β , β-二氟酰胺的途径。
• Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke
  作者：Steven D. Linton、Teresa Aja、Peter R. Allegrini、Thomas L. Deckwerth、Jose-Luis Diaz、Bastian Hengerer、Julia Herrmann、Kathy G. Jahangiri、Joerg Kallen、Donald S. Karanewsky、Steven P. Meduna、Kip Nalley、Edward D. Robinson、Silvio Roggo、Giorgio Rovelli、Andre Sauter、Robert O. Sayers、Albert Schmitz、Robert Smidt、Robert J. Ternansky、Kevin J. Tomaselli、Brett R. Ullman、Christoph Wiessner、Joe C. Wu

  DOI：10.1016/j.bmcl.2003.12.106

  日期：2004.5

  Structural modifications were made to a previously described acyl dipeptide caspase inhibitor, leading to the oxamyl dipeptide series. Subsequent SAR studies directed toward the warhead, P2, and P4 regions of this novel peptidomimetic are described herein. (C) 2004 Elsevier Ltd. All rights reserved.